352 material Form 8-K filings that 310 companies we cover made with the SEC in August 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Ziff Davis reported unaudited second-quarter 2024 revenue of $320.8 million, down 1.6% from a year earlier, and adjusted diluted EPS of $1.18, down 7.1%. GAAP net income rose to $36.9 million, but income from operations fell 26.5%, and the company reaffirmed its fiscal 2024 guidance. The board also raised the share repurchase authorization by 5 million shares to 15 million, which may support per-share results if used.
Q2 2024 revenue $320.8 million, down 1.6% from $326.0 million; income from operations $28.6 million, down 26.5%
Adjusted diluted EPS $1.18, down 7.1% from $1.27; GAAP net income $36.9 million vs. $16.7 million
2024 guidance reaffirmed: revenue $1,411.0 million to $1,471.0 million; adjusted EBITDA $500.0 million to $521.0 million
Board authorized up to 5 million more shares for repurchase on August 2, 2024, for a total of up to 15 million; 8,241,308 shares remained and the program now expires August 2, 2029
Chord Energy reported second quarter 2024 results that include Enerplus from May 31, 2024, when the combination closed. Total revenue rose to $1.26 billion from $912.1 million a year earlier, but net income was $213.4 million, versus $216.1 million, and diluted EPS was $4.25, versus $4.96. The company also declared a $2.52 per share base-plus-variable dividend and updated its FY24 outlook.
Total revenues were $1,260.7 million in 2Q24, versus $912.1 million in 2Q23; net income was $213.4 million, versus $216.1 million, and diluted EPS was $4.25, versus $4.96.
Adjusted EBITDA was $567.9 million and Adjusted diluted EPS was $4.69, versus $3.65 in 2Q23.
Declared a $2.52 per share dividend ($1.25 base, $1.27 variable), payable September 5, 2024 to holders of record as of August 21, 2024.
FY24 pro forma outlook is about $2.9 billion of Adjusted EBITDA and $1.2 billion of Adjusted Free Cash Flow; the company said it remains on target with its 2024 plan.
Primerica reported second-quarter 2024 GAAP net income of $1.2 million, or $0.03 per diluted share, down from $144.5 million a year earlier. The drop reflects $253.6 million in goodwill and other long-lived asset impairments tied to the company's exit from the Senior Health business, and the company says it excluded these items from its adjusted results, where adjusted operating earnings per diluted share rose 18% to $4.71.
GAAP diluted EPS was $0.03 versus $3.97 a year earlier; net income was $1.2 million versus $144.5 million.
Total revenues rose 17% to $803.4 million, including $50 million in insurance claim proceeds; adjusted operating revenues rose 9% to $753.3 million.
Adjusted operating EPS was $4.71, up from $3.99; adjusted net operating income rose 12% to $162.7 million.
The Board approved a 20% dividend increase to $0.90 per share, payable September 12, 2024; the company repurchased $142.7 million of common stock in the quarter.
Crane NXT reported second quarter 2024 sales of $370.6 million, up 5.2% from a year earlier, driven mainly by the acquired OpSec Security business. GAAP earnings per diluted share fell to $0.72 from $0.75, and Adjusted EPS fell to $1.06 from $1.12, while the company narrowed its full year Adjusted EPS guidance to $4.20 to $4.35 from $4.10 to $4.35.
Q2 2024 net sales of $370.6 million, up $18.2 million or 5.2%; OpSec added $20.5 million (5.8%) and core sales grew 0.8%
GAAP operating profit margin was 18.2%, down from 19.5%; Adjusted operating profit margin was 24.1%, down from 26.5%
Full year Adjusted EPS guidance narrowed to $4.20 to $4.35 from $4.10 to $4.35
Quarterly dividend of $0.16 per share declared, payable September 11, 2024 to holders of record as of August 30, 2024
ICU Medical reported second quarter 2024 revenue of $596.5 million, up from $549.3 million a year earlier, but its GAAP net loss widened to $21.4 million, or $0.88 per share, from $9.9 million, or $0.41 per share. The company also narrowed its full-year 2024 guidance, raising the low end of its adjusted diluted EPS range to $4.95 from $4.40, which shareholders will weigh against lower second quarter adjusted EPS of $1.56 versus $1.88.
Second quarter revenue was $596.5 million versus $549.3 million; GAAP gross margin was 35% in both periods.
Adjusted diluted EPS was $1.56 versus $1.88, and adjusted EBITDA was $91.3 million versus $98.1 million.
FY2024 adjusted EBITDA guidance narrowed to $345 million to $365 million from $330 million to $370 million.
FY2024 adjusted diluted EPS guidance updated to $4.95 to $5.35 from $4.40 to $5.10; GAAP net loss guidance narrowed to $(118) million to $(108) million.
Dolby reported fiscal third-quarter 2024 revenue of $288.8 million, down from $298.4 million a year earlier, while GAAP net income rose to $38.4 million, or $0.40 per diluted share, from $16.4 million, or $0.17. The company also declared a $0.30 per share dividend and raised its stock repurchase authorization by $350 million to about $422 million, and gave full-year fiscal 2024 revenue guidance of $1.27 billion to $1.29 billion.
Total revenue was $288.8 million, versus $298.4 million in the third quarter of fiscal 2023.
GAAP net income was $38.4 million, or $0.40 per diluted share; non-GAAP net income was $68.8 million, or $0.71 per diluted share.
Full-year fiscal 2024 revenue is expected to range from $1.27 billion to $1.29 billion, with GAAP diluted EPS of $2.40 to $2.55.
Dividend of $0.30 per share is payable August 27, 2024, to holders of record on August 19, 2024.
Assured Guaranty reported second quarter 2024 results. GAAP net income attributable to the company was $78 million, or $1.41 per diluted share, down from $125 million, or $2.06, a year earlier. Adjusted operating income rose to $80 million, or $1.44 per share, from $36 million, or $0.60, and the company returned $169 million to shareholders in the quarter.
GAAP net income attributable to Assured Guaranty Ltd. was $78 million, or $1.41 per diluted share, in Q2 2024, versus $125 million, or $2.06, in Q2 2023.
Adjusted operating income was $80 million, or $1.44 per share, in Q2 2024, versus $36 million, or $0.60, in Q2 2023.
Capital returned to shareholders in Q2 2024 totaled $169 million, including $152 million of share repurchases and $17 million of dividends.
A $300 million stock redemption by Assured Guaranty Inc. was completed on August 5, 2024, after the AGM merger into AG on August 1.
Digi International reported fiscal third-quarter 2024 results for the period ended June 30, 2024, with revenue down 6% to $105 million while net income rose to $10 million from $7 million. Management said it expects fiscal 2024 revenue to fall about 5% and Adjusted EBITDA to rise about 1%, in line with prior guidance, and that Annualized Recurring Revenue (ARR) growth for the year now exceeds 5%.
Q3 revenue was $105 million, down 6%; diluted EPS was $0.26 versus $0.18 a year earlier
Adjusted net income per diluted share was $0.50, flat year over year
ARR reached $113 million at quarter end, up 9%; Q4 revenue is estimated at $102 million to $106 million
Net debt was $152 million at quarter end after revolver payments; interest expense fell to $3.2 million from $6.6 million
Safety Insurance Group reported second quarter 2024 net income of $16.6 million, or $1.13 per diluted share, down slightly from $17.0 million, or $1.15 per share, a year earlier. Net earned premiums rose 22.1% to $246.9 million, while the combined ratio improved to 99.9% from 101.9%, helped by a $9.7 million favorable effect from the Massachusetts FAIR Plan restructuring. The board also declared a $0.90 quarterly dividend.
Q2 2024 net income was $16.6 million, or $1.13 per diluted share, versus $17.0 million, or $1.15, in Q2 2023
Non-GAAP operating income per diluted share was $1.18, compared with $0.80 a year earlier
Losses and loss adjustment expenses rose 20.4% to $172.7 million; the combined ratio was 99.9% versus 101.9%
Quarterly dividend of $0.90 per share is payable September 13, 2024, to holders of record on September 3, 2024
Kulicke & Soffa reported fiscal third-quarter 2024 net revenue of $181.7 million, down 4.9% from a year earlier, and GAAP net income of $12.3 million, or $0.22 per diluted share, compared with $4.2 million a year earlier. For the nine months, the company posted a GAAP net loss of $81.1 million, which includes $44.5 million in impairment charges, and it guided fourth-quarter net revenue to about $180 million, plus or minus $10 million.
Q3 net revenue $181.7 million, down 4.9% from $190.9 million in fiscal Q3 2023 and up 5.6% from fiscal Q2 2024
GAAP net income $12.3 million, or $0.22 per diluted share, versus $4.2 million, or $0.07, a year earlier; non-GAAP net income $19.3 million, or $0.35 per share, down 39.4%
Nine-month GAAP net loss of $81.1 million, including $44.5 million in impairment charges
Q4 fiscal 2024 outlook: net revenue about $180 million plus or minus $10 million; GAAP diluted EPS about $0.22 plus or minus 10%; the company repurchased 0.9 million shares for $44.0 million in the quarter
Payoneer reported second-quarter 2024 revenue of $239.5 million, up 16% year-over-year, and raised its 2024 guidance. Net income fell 29% to $32.4 million, which shareholders should weigh against the revenue and adjusted EBITDA gains. The company also acquired Skuad on August 5 for $61 million in cash, plus up to $20 million in contingent payments.
Q2 2024 revenue was $239.5 million, up 16% from $206.7 million a year earlier
Net income was $32.4 million, down 29% from $45.5 million; adjusted EBITDA was $72.8 million, up 30%
2024 revenue guidance is $920 million to $930 million; adjusted EBITDA guidance is $225 million to $235 million
Skuad was acquired on August 5 for $61 million cash, subject to adjustments, plus up to $20 million in contingent payments
Diebold Nixdorf reported second-quarter 2024 revenue of $939.7 million, up 1.9% from a year earlier, and GAAP operating profit of $70.7 million, compared with a loss of $3.9 million in the prior-year quarter. The company raised its full-year adjusted EBITDA guidance to $435 million-$450 million from $410 million-$435 million, but cut its full-year revenue outlook to flat from low single-digit growth, so shareholders get a mixed picture.
Q2 2024 GAAP net income was $14.8 million, versus a net loss of $677.3 million a year earlier, which included reorganization items.
Q2 2024 adjusted EBITDA was $118.8 million, up 40.9% from $84.3 million in the prior-year quarter.
Full-year 2024 revenue outlook was changed to flat, from low single-digit growth, citing retail product market headwinds and a modest unfavorable currency impact.
Free cash flow conversion outlook was unchanged at +25%.
DNOW Inc. reported second-quarter 2024 results for the quarter ended June 30, 2024. Revenue rose from $594 million a year earlier, but GAAP net income attributable to DNOW fell from $34 million to $24 million, and diluted EPS fell from $0.31 to $0.21, while non-GAAP diluted EPS held at $0.25.
Q2 2024 revenue was $633 million, compared with $594 million in Q2 2023.
GAAP diluted EPS was $0.21, compared with $0.31 in Q2 2023; non-GAAP diluted EPS excluding other costs was $0.25, unchanged from the prior year.
EBITDA excluding other costs was $50 million, or 7.9% of revenue, compared with $47 million in Q2 2023.
Cash and cash equivalents were $197 million with zero long-term debt at June 30, 2024; the company repurchased $10 million of stock in the quarter and expects to complete its $80 million buyback program this year.
Wolverine World Wide reported second-quarter 2024 revenue of $425.2 million, down 27.8% from $589.1 million a year earlier, and diluted earnings per share of $0.17 versus $0.30. The company raised parts of its full-year 2024 outlook, including diluted EPS of $0.53 to $0.63 (previously $0.43 to $0.63) and ongoing revenue of $1.71 billion to $1.73 billion, while the year-over-year declines reflect divestitures and lower sales.
Q2 2024 diluted EPS was $0.17 versus $0.30 a year earlier, down 43.3%; adjusted diluted EPS was $0.15 versus $0.19.
Ongoing revenue for the quarter was $424.8 million, down 18.4% from $520.8 million; the company cited divestitures of Keds, Wolverine Leathers and Sperry.
Full-year 2024 diluted EPS guidance is $0.53 to $0.63, and ongoing revenue guidance is $1.71 billion to $1.73 billion.
Inventory at quarter end was $297.1 million, down 54.1% from the prior year, and net debt was $666 million.
Bio-Techne reported fourth-quarter fiscal 2024 net sales up 2% to $306.1 million, with organic revenue up 1%, while GAAP earnings per share fell to $0.25 from $0.47 a year earlier. Full-year net sales rose 2% to $1.2 billion, but full-year GAAP EPS fell to $1.05 from $1.76, and the company also announced a cash dividend in a separate press release.
Q4 GAAP operating income fell 52% to $45.8 million; adjusted operating income fell 9% to $101.8 million
Q4 adjusted EPS was $0.49 versus $0.55 a year earlier; full-year adjusted EPS was $1.77 versus $1.99
Diagnostics and Genomics segment Q4 net sales rose 15% to $90.7 million, while Protein Sciences Q4 net sales fell 4% to $214.0 million
Full-year cash flow from operations rose 18% to $299.0 million; the filing does not state the dividend amount
Innospec reported second-quarter 2024 net sales of $435.0 million, down 9% from $480.4 million a year earlier, while net income rose to $31.2 million, or $1.24 per diluted share, from $28.9 million, or $1.16. Management said Oilfield Services sales were hit by lower production chemical activity and expects lower sales there to continue through the second half of 2024, while Performance Chemicals and Fuel Specialties improved.
Net sales were $435.0 million versus $480.4 million; net income was $31.2 million, or $1.24 per diluted share, versus $28.9 million, or $1.16.
Oilfield Services operating income fell to $7.3 million from $28.0 million, while Performance Chemicals operating income rose to $21.2 million from $9.2 million.
Adjusted non-GAAP EPS was $1.39 per diluted share, compared with $1.28 a year earlier.
As of June 30, 2024, the company had $240.2 million in cash and cash equivalents and no debt.
National Vision reported second-quarter 2024 net revenue from continuing operations of $451.7 million, up 4.6%, but swung to a net loss from continuing operations of $(1.0) million, compared with income of $3.6 million a year earlier. The company revised its fiscal 2024 outlook downward, with CEO Reade Fahs saying sales needed a greater inflection to deliver the originally expected results. For shareholders, the lower guidance and new transformation actions signal that the company expects slower progress than previously planned.
Q2 2024 net revenue from continuing operations rose 4.6% to $451.7 million; diluted EPS from continuing operations was $(0.01), versus $0.05 a year earlier
Q2 2024 Adjusted Operating Income rose 13.8% to $14.1 million; Adjusted Diluted EPS was $0.15 versus $0.12
Updated fiscal 2024 outlook (as of August 7, 2024) lowers net revenue to $1.820 billion to $1.840 billion and Adjusted Operating Income to $57 million to $62 million, versus prior continuing-operations ranges of $1.825 billion to $1.865 bil
Company is reviewing all stores to optimize its fleet; Alex Wilkes to become President effective August 19, 2024
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.